|
| |
Overview
Financial Highlight
HeadlinesBusiness Background IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The firm receives the largest proportion of revenue through its Parkway Pantai segment, which operates hospitals and provides healthcare services in Asia. Two of Parkway Pantai’s key markets are Singapore and Malaysia. The second-largest proportion of revenue comes from Acibadem Holdings, a hospital operator and service provider in Central and Eastern Europe, the Middle East, and North Africa.
  RainT this IHH is control by big players share price tend to stay in the same range for long time will up or not , largely depend on the big funds we small ikan bilis can only buy when there is dip and keep for long term knowing that IHH 1 day will worth more than RM12.00 per share (given its huge operation & resilient demand on health care) 28/01/2019 9:36 AM Kaka22 I have a feeling funds are changing hands in the open market. An investor sold 60millon ihh shares in hong kong at 5.57 per share and it was well over subscribed. Especially the period when price stayed 5.7 for more than 5 days in a row. It was kept at that price intentionally. 29/01/2019 11:22 AM commonsense I don’t think investors have any doubts on IHH management team capabilities to operate the vast hospital networks under the company’s brand. The team which is led by Dr Tan has a proven track record of delivering growth for both the revenue and profit to shareholders. In FY13 the revenue and core profit were only at RM6.8bil and RM650mil respectively. For FY18 the company is expected to deliver a revenue of around RM11.5bil and a core profit of around RM850mil. This translate to an average growth rate of 11.1% for revenue and 5.5% for core profit to shareholders. For FY19, analysts are projecting IHH to deliver a profit of around RM990mil driven by growth from mainly the Indian, Turkish and China markets. However, the issue with IHH has always been its very high valuation. At the current share price and using the projected profit of RM990mil for FY19, the company is already being valued at 50x forward PE. Any future profit growth would have already been baked into the share price with limited room for any profit disappointments. A doubling of profit to RM2bil for example ( not in the next 5 years in my opinion) would still value the company at around 25x PE and this is assuming share price remain constant. If you are looking to diversify your portfolio outside of IHH (due to its very high valuation), I would recommend you to look at MBMR. MBMR is a direct proxy to Perodua via its 22.6% interest in the company. Valuation is cheap at only 6.9x PE (based on target FY18 profit of RM145mil. 9m profit is already RM106mil). PB is low at only 0.7x BV. 4Q18 results is expected to be higher than 3Q18 and last year's 4Q17. FY19 growth will be driven by the still high demand of the new Myvi and the newly launched SUV Aruz and also the newly revamp Alza in 2H19. The recent announcement of closure and potential disposal of the loss-making alloy wheel manufacturing business alone is expected to boost the company’s profit by an additional RM20mil. I am projecting a profit to shareholder of RM170 mil for FY19 which at the current price values MBMR at only 5.9x PE. Please go through the analyst reports (https://klse.i3investor.com/servlets/stk/pt/5983.jsp) and do your own analysis before making any decisions. There are 8 analysts in total covering the stock with most of them having a TP of above RM3 (all have a buy rating). The average TP for the 8 analysts is around RM3.50. Good luck. 10/02/2019 9:55 PM NoStyle This is a share with alot of interest from foreign investors. Hong Kees and Singaporeans make up a huge portion of investors. 3 months back, Mitsui from Japan paid a premium of RM 6 to acquire a 16% stake in IHH. With the IHH management being run by capable corporate heads, this is the share for the long term. 12/02/2019 11:36 AM Nirvanaaccountsdept @NoStyle...since you are an accomplice with Kaka22 can you kindly contact the accounts dept of Nirvana...there is an outstanding invoice for rm 24,444.44cts incurred during the funeral of Kaka22 father.Unless IHH goes up to rm 6 soon NO style will also be owing Nirvana when his family HKC...HAM KA CHAN 26/02/2019 8:41 AM RainT 400% increase in net profit ...gila must be dont know what accounting items need exclude all these non operating , accounting items then see the operating profit 27/02/2019 5:49 PM RainT @limbeh please do some homework take all the recent 4 quarters profit & exclude all the accounting items , the non operating items then u will find out the real PE is not that high 27/02/2019 5:51 PM RainT have forex gain 457 million what a joke.....exclude this actually is making loss lol 27/02/2019 5:53 PM RainT IHH we can only trust its long term prospect only as IHH is big and demand is very high cannot study & predict the quarter report ...you will GILA ...hahaha 27/02/2019 5:54 PM RainT ooppss....sorry is wrong not making loss if exclude the forex 457 million & other accounting items profit is 341 million (not as reported 509 million) ok la,still good ....as IHH sales go up a lot 27/02/2019 5:56 PM RainT core operating profit increase 11% quarter on quarter increase 88% year on year good expansion & good profit keep long term , add more shareholding when there is dip due to temporary bad news 28/02/2019 6:00 PM  James Ng https://klse.i3investor.com/blogs/general/196115.jsp [转贴] [Facebook live:浅谈IHH Healthcare bhd (IHH)] - James的股票投资James Share Investing 03/03/2019 11:48 AM Kaka22 March 14 court case pls drop back to 5.1 my entry price as i want to collect more. Only sohailawrgan dunno value of this stock. So stupid. Bark for nuts. Still stuck at supermx 1.70 wakakakaka 05/03/2019 5:57 PM Kaka22 Smart ppl make money stupid ppl copy smart ppl’s id and bark nonsense.. see also laugh... hahaha 06/03/2019 8:05 PM Kaka22 Hahaha betul betul so hai. Only stupid ppl like you think this counter cannot reach 6. So stupid.. duno how to value stock and read p/l statement. Continue be copycat and copy my id and talk cock thats the best for you already. Nothing more from a stupid genetic family of u. 07/03/2019 2:58 PM Kaka22 Ppl making money now laughing at you hahahaha u follow me come here also dunno buy when i call it at 5.1 lol free money for i to buy coffin... too bad now u die without one cos u have poor mentality.. just burn when die ok 07/03/2019 2:59 PM Kaka22 Im gonna change id u cannot follow me and my stock picks anymore hahaha .... loser.... go fuck yourself... sold at 5.9 cos found an even better prospect... will buy this again when time is right... only loser like u dunno how to properly strategize investment.. no wonder still stuck 1.7 at supermX hahaha loser... go fuck yourself and your entire family.... bye bye... thanks for all the funny entertainment... 180 and 360 degrees also dunno hahahaha i will remember forever this world got such stupid ppl exist hahaha so hai... nah ..I.. diu lei mou mou ham ka chan... lei lou mou so hai pei gao diu la... lol 07/03/2019 3:02 PM sooaria Should Fortis successfully recover the sum and be liable for claims made over the brandnames, IHH could potentially make a writeback amounting to c.RM100m 02/04/2019 4:07 PM RainT hold on don't rush in buy more IHH expect more shock come in...more accounting items come in.... will shock and drop more wait and see 02/04/2019 11:44 PM sooaria Do not be afraid of the accounting items big name, these will be sorted out accordingly later in a safe manner 03/04/2019 8:18 AM Got Offfer From UBS Shanghai - Bye Bye The last time somebody said that a company went bankrupt 03/04/2019 8:30 AM t_nike2002 This week The Edge (8 Apr 19) has detailed coverage on IHH. Excerpt from the article "Of the analysts who have covered IHH since end- Feb this year, 10 have Positive calls - "Buy, Outperform, Add or Overweight", 4 "Hold/ Neutral" calls and 3 "underweight, underperform or sell" calls. Credit Suisse has an "Outperform" call and target price of RM6.50 while UBS has 12 month target price of RM6.60 and a buy call. The rest you can rest from the edge.. 08/04/2019 9:54 AM RainT IHH ...sure will collect more it is 2nd largest hospital chain in the world also healthcare is a need for many people 17/04/2019 3:28 PM RainT don't be confused by its high PE ya you need do some homework and analysis its operating profit only , then you will know it is expensive or not , or just at the correct price only 17/04/2019 3:29 PM RainT with expansion in Hong Kong, China, India , Singapore all this will be good for IHH 17/04/2019 3:30 PM RainT The Japanese willing to pay more to buy from Khazanah this IHH shares so as long as the share price still lower than Mitsui buy price , worth to consider for invest 17/04/2019 3:44 PM RainT the Japanese will no so stupid to buy expensive and no growth company they must have be able to see something that we cannot see and believe on its long term prospect so Mitsui willing to pay more to acquire shares from Khazanah 17/04/2019 3:45 PM RainT want to wait for weakness in IHH share price ? wait for next quarter result , will have accounting items to make the profit drop or loss , then that is the buy time 17/04/2019 3:46 PM RainT from few quarters until always will have bad news and accounting items in quarter report just wait & see for IHH , don't chase high , you will get stuck 17/04/2019 3:47 PM RainT wait for quarter report bomb , big drop and buy again another batch like IHH biz & will hold long term 18/05/2019 12:22 PM  |
|
